These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 30068492)

  • 21. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
    Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
    Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.
    Mostile G; Nicoletti A; Cicero CE; Cavallaro T; Bruno E; Dibilio V; Luca A; Sciacca G; Raciti L; Contrafatto D; Chiaramonte I; Zappia M
    Neurol Sci; 2016 Apr; 37(4):591-5. PubMed ID: 26820655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
    Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
    Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study.
    Bianco MG; Cristiani CM; Scaramuzzino L; Sarica A; Augimeri A; Chimento I; Buonocore J; Parrotta EI; Quattrone A; Cuda G; Quattrone A
    Parkinsonism Relat Disord; 2024 Jun; 123():106978. PubMed ID: 38678852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of quantitative MRI parameters in discriminating progressive supranuclear palsy from Parkinson's disease.
    Onder H; Kocer BG; Turan A; Comoglu S
    Neurol Res; 2023 Aug; 45(8):738-744. PubMed ID: 37068211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.
    Nakahara K; Nakane S; Kitajima M; Masuda-Narita T; Matsuo H; Ando Y
    J Neurol; 2020 Mar; 267(3):752-759. PubMed ID: 31745723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.
    Miyata M; Kakeda S; Yoneda T; Ide S; Okada K; Adachi H; Korogi Y
    Neuroradiology; 2023 Apr; 65(4):719-727. PubMed ID: 36670276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study.
    Quattrone A; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Morelli M; Nigro S; Vescio B; Bianco MG; Vasta R; Arcuri PP; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2021 Mar; 36(3):681-689. PubMed ID: 33151015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.
    Grijalva RM; Pham NTT; Huang Q; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Weigand SD; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
    Mov Disord; 2022 Apr; 37(4):702-712. PubMed ID: 34970796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy.
    Ugga L; Cuocolo R; Cocozza S; Pontillo G; Elefante A; Quarantelli M; Vicidomini C; De Pandis MF; De Michele G; D'Amico A; de Divitiis O; Brunetti A
    Neuroradiology; 2020 Dec; 62(12):1657-1665. PubMed ID: 32710162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of optimal value of magnetic resonance planimetry and the parkinsonism index for the diagnosis of Parkinson's disease and progressive supranuclear palsy.
    Shetty N; Koteshwar P; Priyanka
    J Taibah Univ Med Sci; 2023 Dec; 18(6):1577-1585. PubMed ID: 37701844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.
    Nizamani WM; Mubarak F; Barakzai MD; Ahmed MS
    Int J Gen Med; 2017; 10():375-384. PubMed ID: 29184432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.
    Mueller C; Hussl A; Krismer F; Heim B; Mahlknecht P; Nocker M; Scherfler C; Mair K; Esterhammer R; Schocke M; Wenning GK; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Sep; 54():90-94. PubMed ID: 29643007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
    Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
    Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
    Morelli M; Arabia G; Salsone M; Novellino F; Giofrè L; Paletta R; Messina D; Nicoletti G; Condino F; Gallo O; Lanza P; Quattrone A
    Mov Disord; 2011 Feb; 26(3):527-33. PubMed ID: 21287599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
    Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.